{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:43:37Z","timestamp":1787013817271,"version":"build-2736575974"},"reference-count":16,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust NZ J Obst Gynaeco"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>We hypothesise that PTNS is a safe and effective treatment for OAB. Overactive bladder (OAB) is estimated to affect 11.8% of women worldwide, causing diminished quality of life. Lifestyle modifications, muscarinic receptor antagonist and beta\u2010adrenoreceptor agonist remain the mainstay of treatment but are limited by their efficacy and adverse effects. Access to third\u2010line therapies of intravesical botulinum toxin type A or sacral neuromodulation is limited by their invasive nature. Percutaneous tibial nerve stimulation (PTNS) has emerged as a non\u2010invasive treatment option for OAB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study was a single\u2010arm trial of women requesting third\u2010line treatment for OAB. The primary treatment outcome was patient\u2010reported visual analogue score (VAS) improvement of at least 50%. Secondary outcome measures were Urinary Distress Inventory Short Form (UDI\u20106) score and two\u2010day bladder diary. Patients also provided feedback on adverse effects encountered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the 84 women recruited, initial treatment protocol showed a success rate of 77.2% among those who completed treatment based on VAS, with a statistically significant improvement in mean UDI\u20106 score of 20.13 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01, standard deviation: 12.52). Continued success following tapering protocol of 60.8% and a mean maintenance protocol of 14.2\u2009months was achieved. No adverse effects were reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The results from this study are in concordance with previously published literature on the effectiveness and safety of PTNS as a treatment modality for OAB. Further randomised controlled trials to evaluate the optimal treatment protocol are warranted to establish a standardised regime.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ajo.13822","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T01:33:25Z","timestamp":1713404005000},"page":"501-505","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Percutaneous tibial nerve stimulation for the overactive bladder: A single\u2010arm trial"],"prefix":"10.1111","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8001-3531","authenticated-orcid":false,"given":"Hnin Yee","family":"Kyaw","sequence":"first","affiliation":[{"name":"Gold Coast University Hospital  Southport Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8234-0417","authenticated-orcid":false,"given":"Hannah G.","family":"Krause","sequence":"additional","affiliation":[{"name":"Gold Coast University Hospital  Southport Queensland Australia"},{"name":"University of Queensland  St Lucia Queensland Australia"},{"name":"Ramsay Specialist Centre Greenslopes Private Hospital  Greenslopes Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith T.W.","family":"Goh","sequence":"additional","affiliation":[{"name":"Gold Coast University Hospital  Southport Queensland Australia"},{"name":"Ramsay Specialist Centre Greenslopes Private Hospital  Greenslopes Queensland Australia"},{"name":"Griffith University School of Medicine  Gold Coast Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22609"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00192\u2010015\u20102932\u20101"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/039156030807500103"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442\u20102042.2007.01976.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.09.019"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.06.113"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.12.036"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22266"},{"key":"e_1_2_7_10_1","unstructured":"International Urogynaecological Association \u2013 Your Pelvic Floor patient information.https:\/\/www.yourpelvicfloor.org\/conditions\/percutaneous\u2010tibial\u2010nerve\u2010stimulation\u2010ptns\/. Accessed 15 January 2023."},{"key":"e_1_2_7_11_1","unstructured":"New MBS items for Percutaneous Tibial Nerve Stimulation (PTNS) for the treatment of idiopathic overactive bladder(2018)http:\/\/www.mbsonline.gov.au\/internet\/mbsonline\/publishing.nsf\/Content\/Factsheet\u2010PTNS. Accessed 15 January 2022."},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.05.045"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2015.05.014"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003193.pub4"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12955\u2010021\u201001721\u2010z"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464\u2010410X.2006.06055.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.01.078"}],"container-title":["Australian and New Zealand Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajo.13822","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T06:13:18Z","timestamp":1734675198000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/ajo.13822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1111\/ajo.13822"],"URL":"https:\/\/doi.org\/10.1111\/ajo.13822","archive":["Portico"],"relation":{},"ISSN":["0004-8666","1479-828X"],"issn-type":[{"value":"0004-8666","type":"print"},{"value":"1479-828X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"assertion":[{"value":"2023-11-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}